Results 11 to 20 of about 191,064 (352)

Chronic heart failure with reduced ejection fraction [PDF]

Canadian Medical Association Journal, 2014
See also page [510][1] and [www.cmaj.ca/lookup/doi/10.1503/cmaj.131742][2] Heart failure with reduced ejection fraction is a clinical syndrome of dyspnea, exercise intolerance and/or edema resulting from an impairment of ejection of blood, usually documented by a left ventricular ejection ...
Yasbanoo, Moayedi, Jeremy, Kobulnik
openaire   +2 more sources

Heart Failure With Mid-range Ejection Fraction: Every Coin Has Two Sides

Frontiers in Cardiovascular Medicine, 2021
This review summarizes current knowledge regarding clinical epidemiology, pathophysiology, and prognosis for patients with HFmrEF in comparison to HFrEF and HFpEF. Although recommended treatments currently focus on aggressive management of comorbidities,
Kaiyuan Zhu, Teng Ma, Yang Su, Xin Pan, Rongrong Huang, Fenglei Zhang, Chunxi Yan, Dachun Xu, Dachun Xu   +8 more
doaj   +1 more source

Five‐year mortality of heart failure with preserved, mildly reduced, and reduced ejection fraction in a 4880 Chinese cohort

ESC Heart Failure, 2022
Aims Available evidence is incomplete and inconsistent in the outcomes of heart failure (HF) patients with preserved ejection fraction (HFpEF), mildly reduced ejection fraction (HFmrEF), and reduced ejection fraction (HFrEF).
Shiqun Chen, Zhidong Huang, Yan Liang, Xiaoli Zhao, Xiemuxikaimaier Aobuliksimu, Bo Wang, Yibo He, Yu Kang, Haozhang Huang, Qiang Li, Younan Yao, Xiaozhao Lu, Xiaoxian Qian, Xujing Xie, Jin Liu, Yong Liu   +15 more
doaj   +1 more source

A comparison of clinical outcomes following atrial fibrillation ablation for heart failure patients with preserved or reduced left ventricular function: A systematic review and meta-analysis

Indian Pacing and Electrophysiology Journal, 2022
Background: This review aims to determine if patients who undergo atrial fibrillation (AF) ablation with heart failure with preserved ejection fraction (HFpEF) do better, or worse or the same compared to patients with heart failure with reduced ejection ...
Gaurav Panchal, Chun Shing Kwok, Adrian Morley-Davies, Donah Zachariah, Thanh Phan   +4 more
doaj   +1 more source

Understanding How Heart Metabolic Derangement Shows Differential Stage Specificity for Heart Failure with Preserved and Reduced Ejection Fraction

Biomolecules, 2022
Heart failure (HF) is a clinical condition defined by structural and functional abnormalities in the heart that gradually result in reduced cardiac output (HFrEF) and/or increased cardiac pressures at rest and under stress (HFpEF).
Federico Ferro, Renza Spelat, Camilla Valente, Paolo Contessotto   +3 more
doaj   +1 more source

Discriminative Value of Serum Irisin in Prediction of Heart Failure with Different Phenotypes among Patients with Type 2 Diabetes Mellitus

Cells, 2022
Recent studies have shown that circulating levels of irisin are prognostic factors in heart failure (HF), but no data are available on the predictive role of irisin in patients with type 2 diabetes mellitus (T2DM) and different phenotypes of HF.
Alexander A. Berezin, Michael Lichtenauer, Elke Boxhammer, Eric Stöhr, Alexander E. Berezin   +4 more
doaj   +1 more source

Sirt1 Activity in PBMCs as a Biomarker of Different Heart Failure Phenotypes

Biomolecules, 2020
Heart Failure (HF) is a syndrome, which implies the existence of different phenotypes. The new categorization includes patients with preserved ejection fraction (HFpEF), mid-range EF (HFmrEF), and reduced EF (HFrEF) but the molecular mechanisms involved ...
Valeria Conti, Graziamaria Corbi, Maria Vincenza Polito, Michele Ciccarelli, Valentina Manzo, Martina Torsiello, Emanuela De Bellis, Federica D’Auria, Gennaro Vitulano, Federico Piscione, Albino Carrizzo, Paola Di Pietro, Carmine Vecchione, Nicola Ferrara, Amelia Filippelli   +14 more
doaj   +1 more source

Therapeutic Stalemate in Heart Failure With Preserved Ejection Fraction

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
The findings of randomized trials of neurohormonal modulation have been neutral in heart failure with preserved ejection fraction and consistently positive in heart failure with reduced ejection.
Rohan Samson, Thierry H. Le Jemtel
doaj   +1 more source

Heart failure with reduced ejection fraction

Nature Reviews Disease Primers, 2017
Heart failure is a global public health problem that affects more than 26 million people worldwide. The global burden of heart failure is growing and is expected to increase substantially with the ageing of the population. Heart failure with reduced ejection fraction accounts for approximately 50% of all cases of heart failure in the United States and ...
Bloom, Michelle W., Greenberg, Barry H., Jaarsma, Tiny, Januzzi, J., Lam, Carolyn S.P., Maggioni, Aldo P., Trochu, Jean N., Butler, Javed   +7 more
openaire   +6 more sources

Heart failure with mid‐range ejection fraction: pro and cons of the new classification of Heart Failure by European Society of Cardiology guidelines

ESC Heart Failure, 2020
Currently, the assessment of left ventricular ejection fraction (LVEF) is the cornerstone of the classification of patients with heart failure (HF). The mid‐range LVEF (HFmrEF) category was identified in an attempt to uncover specific characteristics of ...
Luca Branca, Marco Sbolli, Marco Metra, Marat Fudim   +3 more
doaj   +1 more source